What’s New in the CTN?
Updates from the NIDA National Drug Abuse Treatment Clinical Trials Network. Want to share some news about your protocol, node, publications or presentations, or other CTN-related work here and/or in the CTN Bulletin? Email us at ctnlib@uw.edu!
Development & Use of an Interactive Online Dashboard for CTN-0135
CTN-0135, Buprenorphine Treatment Engagement and Induction Problems Among Individuals Using Fentanyl, examined whether fentanyl use and challenges starting buprenorphine/naloxone treatment vary across different regions in the U.S. The study also surveyed clinicians to better understand the challenges they face when starting buprenorphine treatment for patients using fentanyl and how they are adapting standard clinical protocols to better engage patients in care. Recognizing that scientific journals have low overall reach, particularly for non-scientific audiences, the study team created an interactive online data dashboard to make the data more accessible. After developing…
News from the Health Systems Node
Join the CTN Health Systems Node for two upcoming virtual seminars. On Thursday, August 6, 2026, Caitlin Ryus, MD, MPH, Assistant Professor in the Department of Emergency Medicine at Yale School of Medicine, will discuss a Connecticut-based study that links administrative data from homelessness services and electronic health records to examine the relationship between rapid rehousing and substance-related emergency department visits. On Thursday, September 3, 2026, Tessa Matson, PhD, MPH, Collaborative Scientist at Kaiser Permanente Washington Health Research Institute, will present findings from a CTN implementation trial on factors that distinguished clinics that successfully…
New in the Library (June – July 2026)
Here are the latest items added to the CTN Dissemination Library for June – July 2026 (this post will be updated as new items come in): Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial. McNeely J, et al. Addiction 2026 (in press). (Primary outcomes for CTN-0101) State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset. Bórquez I, et al. Addiction 2025;120(6):1207-1222. (CTN-0112) Actions needed for pharmacy-dispensed methadone for opioid use…
News from the Southern Consortium Node: New CTN SIG: Substance Use Research in Non-Traditional Settings
Join the new NIDA Clinical Trials Network Special Interest Group on Substance Use Research in Non-Traditional Settings! Led by the Southern Consortium Node, this SIG will bring together researchers and community partners interested in advancing substance use prevention, treatment, recovery, harm reduction, and implementation research in community-based settings outside of traditional specialty treatment programs. Topics include research in: Meetings will feature research presentations, discussion of emerging evidence and funding opportunities, networking, and collaboration on future research initiatives. First Meeting: Wednesday, August 19, at 2:00 p.m. ET Meeting Link (Microsoft Teams): CTN SIG Substance…
THIS WEDNESDAY (July 15): National Contingency Management Community of Practice
The National Contingency Management (CM) Community of Practice (CoP), led by Michigan Medicine (University of Michigan), is intended to serve as a collaborative learning forum, bringing together researchers, treatment providers, implementers, TTA leaders, state agencies, and other partners in CM interested in expanding access to evidence-based CM. The goal is to create a practical, engaging, and implementation-focused space to share best practices, discuss challenges and solutions, and support broader adoption and sustainability of evidence-based CM across the U.S. Join the CM CoP monthly meetings to ask questions, share what is…
News from the Pacific Northwest Node: ADAI Symposium on Cannabinoid Hyperemesis Syndrome (Sept. 18, 2026)
The CTN Pacific Northwest Node is located at the Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington. Every two years, ADAI hosts a symposium related to cannabis. The PNW Node would like to invite you to this year’s event and also encourage anyone familiar with CHS to consider submitting an abstract for a digital poster! The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream September 18, 2026 | 9:00am – 4:00pm PT Attend virtually or in person in Seattle, WA CME accreditation pending for providers; Certificate of attendance available for both in-person and virtual attendees …
CTN T&I SIG Webinar: SUD Treatment Research in the CTN: Portfolio Analysis of Approved Studies, 2000-2024 (July 21, 9am PT)
Join the CTN Translation & Implementation SIG for their next meeting, July 21, 2026, 9-10am PT. Drs. Sabeeh Baig, Jeremiah Bertz, and Landhing Moran will describe the methods and findings from their comprehensive portfolio analysis of all studies within the CTN approved from 2000 through 2024. Their presentation will highlight scientific areas in the CTN portfolio, portfolio growth trends, and research impact through this period. The presentation will conclude with a discussion of the CTN’s achievements and the strengths of its trial infrastructure. Read more about the speakers. Contact Elena…
News from the Pacific Northwest Node: Mary Hatch Receives Award; Two New Publications about CTN-0082
PNW Node Co-Investigator Mary Hatch Receives UW Departmental Award On June 17, 2026, Mary Hatch, PhD, was awarded the UW Department of Psychiatry & Behavioral Sciences Wayne J. Katon Outstanding Research Mentor Award, which recognizes a faculty member who has demonstrated excellence in research mentoring of faculty members and trainees, including students, residents, fellows, and postdocs. Faculty mentors selected for this award have demonstrated a sustained commitment to fostering the creative, scholarly, professional and personal development of their mentees. Dr. Hatch is Co-Investigator of the NIDA National Drug Abuse Treatment Clinical Trials…
New in the Library (May – June 2026)
Here are the latest items added to the CTN Dissemination Library for May – June 2026 (this post will be updated as new items come in): Probability of fentanyl adulteration in cocaine selectively decreases cocaine demand. Nunez C, et al. Experimental and Clinical Psychopharmacology 2026;34(2):207-215. (Primary outcomes for CTN-0130) Undervaluing nondrug rewards or overvaluing cocaine? Cocaine demand relates to cocaine use severity more strongly than anhedonia in individuals with cocaine use disorder. Nunez C, et al. Experimental and Clinical Psychopharmacology 2026;33(1):91-99. Applying machine learning in predicting medication treatment outcomes for…
HHS Request for Comment on Chronic Disease of Addiction (Deadline July 5)
The US Department of Health and Human Services (HHS) is seeking comment in response to an RFI related to substance research, policy, and strategies to improve the prevention, treatment, and recovery of the chronic disease of addiction and mental illness and “how to promote the Great American Recovery Initiative.” The initiative includes goals to: Learn more and submit your comments here by July 5, 2026
New in the Library (April – May 2026)
Here are the latest items added to the CTN Dissemination Library for April – May 2026 (this post will be updated as new items come in): The community representative council of the National Drug Abuse Treatment Clinical Trials Network: Co-design and early impact [commentary]. Moore SK, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). Experiences of pregnant and postpartum people of color engaged in a randomized clinical trial of medication to treat opioid use disorder during pregnancy: A “Positive Outliers” analysis. Wheeler A, et al. Journal…
News from the Health System Node
A recent publication by Health System Node faculty, Stacy Sterling, DrPH, MSW, MPH, was selected as one of the top Quality Improvement/Implementation Science publications in the Journal of General Internal Medicine: A Randomized Trial of Alcohol Telemedicine in Primary Care: Pharmacotherapy and Referral Outcomes. J Gen Intern Med. 2026 Jan;41(1):6-15. Dr. Sterling presents this project in this JGIM webinar (if you’re not already a JGIM/SGIM member, you must register, but it’s straightforward and free). A new study led by Anh Nguyen, PhD, Health System Node faculty and Investigator at the…
CTN Community Representation Council Meeting Summary (April 2026)
The Clinical Trials Network, funded by the National Institute on Drug Abuse, proudly collaborates with its Community Representative Council (CIRCL). Comprised of 16 members, one for each Node of the CTN, the CIRCL meets bi-monthly to courageously share what’s happening in their communities. The Northeast Node is proud to serve as administrative support for this community-led initiative. Questions about CIRCL – or for CIRCL – can be directed to Bethany.M.McLeman@Dartmouth.edu. This brief is an overview of topics discussed at this meeting and is not an exhaustive review. Download a copy of…
News from the Southwest Node: Webinar on CTN-0096 (June 9, 11am EDT)
The Southwest Node is hosting an upcoming webinar, featuring speakers Kamilla Venner, PhD, and Aimee Campbell, PhD, MSW, and reviewing results from CTN-0096. Partnering with Tribal Serving Programs to Enhance Culture in the Delivery of Substance Use Disorder Treatment June 9, 2026 | 11am EDT | Download flyer This project looked at adding culture to care for Alaska Native and American Indian people who had problems with opioid use. The care was medication treatment. We wanted to see if culture would help more people start and stay in treatment. We…
News from the Greater Intermountain Node: Webinar: Psychedelic-Assisted Interventions for Mental Health & SUD (June 16, 12pm MST)
Join the Greater Intermountain Node on June 16, 2026 (12-1pm MST) for their next GIN on the Rocks webinar: Psychedelic-Assisted Interventions for Mental Health and Substance Use: Current Evidence and Emerging Directions Presenter: Yitong Xin, PhD Psychedelic-assisted interventions have gained significant scientific and public attention, yet many researchers and clinicians remain unfamiliar with the current state of the evidence. This presentation will provide an accessible overview of psychedelic science and emerging clinical evidence across depression, trauma, and substance use, with Dr. Xin highlighting her research program’s contributions across multiple populationsand…
CTN T&I SIG Survey of Implementation Research Interests and Training Needs
Members of the CTN Translation & Implementation Special Interest Group (T&I SIG) from the Center for Dissemination & Implementation At Stanford (C-DIAS) invite you to complete a brief, online survey to understand implementation research interests and training needs in the field of addiction research. The survey is confidential and will take about 5 minutes to complete. After completing the survey, you will have an opportunity to enter your email address on a separate form to receive an aggregate summary of survey findings. If you would like to participate, please access the…
CTN Northeast Node Science Series: Injecting Hope: Repurposing GLP-1 Receptor Agonists for Treating SUDs (May 21, 2026, 12-1pm ET)
Join the CTN Northeast Node for the next installment of their virtual Science Series, featuring presenter Joji Suzuki, MD, FACLP, PI of the SuzukiLab at Brigham and Women’s Hospital, speaking about the use of GLP-1 receptor agonists for treatment substance use disorders (SUDs). This 1-hour session on May 21, 2026 (12-1pm ET) will cover the basic pharmacology of GLP-1 receptor agonists and related medications. Then the emerging evidence-base for their use in treating substance use disorders in humans will be reviewed. Finally, the talk will cover the various issues and…